The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome

Table 2

Research group characteristics.

Indexes	Experiment group (n = 35)	Control group (n = 31)
Age	51.4 ± 13.2	50.5 ± 8.7	0.86
Disease duration	38.1 ± 10.1	38.5 ± 14.2	0.68
PASI	21.8 ± 8.3	22.3 ± 18.3	0.92

Note. Age, disease duration, and PASI of the patients in the two study groups are similar (, Student t-test).